Literature DB >> 16849232

Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Steven Fletcher1, Andrew D Hamilton.   

Abstract

Protein-protein interactions play key roles in a range of biological processes, and are therefore important targets for the design of novel therapeutics. Unlike in the design of enzyme active site inhibitors, the disruption of protein-protein interactions is far more challenging, due to such factors as the large interfacial areas involved and the relatively flat and featureless topologies of these surfaces. Nevertheless, in spite of such challenges, there has been considerable progress in recent years. In this review, we discuss this progress in the context of mimicry of protein surfaces: targeting protein-protein interactions by rational design.

Mesh:

Substances:

Year:  2006        PMID: 16849232      PMCID: PMC1578744          DOI: 10.1098/rsif.2006.0115

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  100 in total

1.  Enfuvirtide, a new drug for HIV infection.

Authors:  Courtney V Fletcher
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

3.  Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition.

Authors:  Jack D Sadowsky; Margaret A Schmitt; Hee-Seung Lee; Naoki Umezawa; Shaomeng Wang; York Tomita; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2005-08-31       Impact factor: 15.419

4.  Drosophila Toll and IL-1 receptor.

Authors:  N J Gay; F J Keith
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

5.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

6.  Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.

Authors:  D Aviezer; S Cotton; M David; A Segev; N Khaselev; N Galili; Z Gross; A Yayon
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

7.  Calorimetric studies of the thermal denaturation of cytochrome c peroxidase.

Authors:  G C Kresheck; J E Erman
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

8.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 9.  Hepatitis C: an epidemiological review.

Authors:  M I Memon; M A Memon
Journal:  J Viral Hepat       Date:  2002-03       Impact factor: 3.728

10.  Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.

Authors:  H Chaib; M A Rubin; N R Mucci; L Li; M L Day; J S Rhim; J A Macoska
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

View more
  57 in total

1.  Controlled protein dimerization through hybrid coordination motifs.

Authors:  Robert J Radford; Phuong C Nguyen; Treffly B Ditri; Joshua S Figueroa; F Akif Tezcan
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

2.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

3.  Heterocyclic alpha-helix mimetics for targeting protein-protein interactions.

Authors:  Shannon M Biros; Lionel Moisan; Enrique Mann; Alexandre Carella; Dayong Zhai; John C Reed; Julius Rebek
Journal:  Bioorg Med Chem Lett       Date:  2007-05-27       Impact factor: 2.823

4.  2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine.

Authors:  Véronique Hamon; Raphael Bourgeas; Pierre Ducrot; Isabelle Theret; Laura Xuereb; Marie Jeanne Basse; Jean Michel Brunel; Sebastien Combes; Xavier Morelli; Philippe Roche
Journal:  J R Soc Interface       Date:  2013-11-06       Impact factor: 4.118

5.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

6.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

7.  Correlations between secondary structure- and protein-protein interface-mimicry: the interface mimicry hypothesis.

Authors:  Jaru Taechalertpaisarn; Rui-Liang Lyu; Maritess Arancillo; Chen-Ming Lin; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2019-03-20       Impact factor: 3.876

Review 8.  Functional protein nanostructures: a chemical toolbox.

Authors:  Seah Ling Kuan; Fernando R G Bergamini; Tanja Weil
Journal:  Chem Soc Rev       Date:  2018-11-19       Impact factor: 54.564

Review 9.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

10.  Beauty is in the eye of the beholder: proteins can recognize binding sites of homologous proteins in more than one way.

Authors:  Juliette Martin
Journal:  PLoS Comput Biol       Date:  2010-06-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.